In 2023, the Steerable Needle Market is expected to be worth US$ 1.09 billion. The market is expected to reach US$ 2.13 billion by 2033, expanding at a 6.9% CAGR throughout the forecast period. Steerable needles have gained significant traction in the healthcare sector, revolutionizing minimally invasive procedures and offering enhanced precision and control.
The rising prevalence of chronic diseases, such as cancer, cardiovascular disorders, and neurological conditions, is propelling the demand for minimally invasive surgical procedures. Steerable needles are playing a vital role in facilitating precise diagnosis, targeted therapy, and effective drug delivery in these treatments.
Patients are increasingly preferring minimally invasive procedures due to their benefits, including shorter recovery times, reduced pain, and lower risk of complications. Steerable needles are integral to these surgeries, allowing surgeons to navigate complex anatomical structures with ease and perform interventions with minimal invasiveness.
Get your Sample Report with Latest Market Information! https://www.futuremarketinsights.com/reports/sample/rep-gb-17591
The steerable needle market is witnessing constant technological advancements, including the development of robotic-assisted steerable needles, advanced imaging techniques, and miniaturization of devices. These innovations are enabling healthcare professionals to perform intricate procedures with improved accuracy and safety.
The steerable needle market is experiencing a surge in research and development activities, with a focus on enhancing device functionality, improving needle design, and exploring new applications. Collaborations between industry players, research institutions, and healthcare facilities are fostering innovation and driving market growth.
Key Takeaways from the Steerable Needle Market:
- The steerable needle market industry in the United States is predicted to reach US$ 676.0 million by 2033, increasing at a 7.0% CAGR.
- The steerable needle market industry in the United Kingdom is estimated to reach a market size of US$ 116.3 million, expanding at a CAGR of 7.2% by 2033.
- During the forecast period, the steerable needle market industry in China is expected to reach a market value of US$ 147.8 million, securing an 7.6% CAGR.
- The steerable needle market industry in Japan is predicted to reach US$ 107.6 million by 2033, increasing at a 7.5% CAGR.
- South Korea’s steerable needle market industry is predicted to achieve a market value of US$ 121.9 million by 2033, rising at a 7.2% CAGR during the forecast period.
- With a CAGR of 6.6% from 2023 to 2033, the bevel-tip flexible needles segment by product is expected to dominate the steerable needle market industry.
- With a CAGR of 5.9% from 2023 to 2033, the biopsy segment by application is expected to drive the global market throughout the forecast period.
- With a CAGR of 6.2% from 2023 to 2033, the hospitals segment by end user is expected to dominate the steerable needle market industry.
Don’t Hesitate To Get In Touch With Our Analyst To Resolve Your Inquiries! https://www.futuremarketinsights.com/ask-question/rep-gb-17591
How Does the Competition Look in the Steerable Needle Market?
The steerable needle market sector is a very competitive one, with large firms fighting for market share. Several significant participants in this industry comprise are Medtronic, Boston Scientific Corporation, Olympus Corporation, Stryker Corporation, Smith & Nephew plc, and Johnson & Johnson among other companies. The major businesses are heavily spending in R&D efforts to create innovative and inventive goods with enhanced effectiveness, dependability, and affordability. They are also focusing on expanding their product line and strengthening their distribution methods in order to fulfil shifting consumer expectations.
Tactical alliances and partnerships with other companies are becoming more common in the industry, allowing parties to leverage one another’s strengths and expand their market influence.
Leading firms use consolidation and mergers to strengthen their market position and gain entry into new markets. The sector is expanding significantly in developing economies, particularly in India and China.
To boost their presence in these regions, major companies are expanding their distribution networks and building regional manufacturing sites. They are also concentrating on offering cost-effective solutions to customers in these markets in order to get a competitive advantage.
Key Players in the Steerable Needle Industry:
- AprioMed
- Elekta Instrument AB,
- Medtronic
- Boston Scientific
- Cook Medical
- Olympus Corporation
- Terumo Corporation
- Merit Medical Systems
- Vygon
- Johnson & Johnson
- B. Braun Melsungen AG
- Stryker Corporation
- Smith & Nephew
- AngioDynamics Inc.
- Teleflex Incorporated
- Argon Medical Devices Inc.
- BD (Becton, Dickinson and Company)
- Cardinal Health Inc.
- Teleflex Medical OEM
- ConMed Corporation
- Mindray Medical International Limited
- Hologic Inc.
Innovative Strategies Unveiled: Customization at the Core of Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-17591
Segmentation Analysis of the Steerable Needle Market:
By Product:
- Bevel-Tip Flexible Needles
- Symmetric-Tip Needles
- Tendonactuated Tips
By Application:
- Biopsy
- Tumor Ablation
- Pain Management
- Neurosurgery
- Cardiac Interventions
- Interventional Radiology
- Robotic-Assisted Procedures
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East & Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
